Similar articles for PMID: 19646076

Year	Number of Results
1914	1
1975	1
1990	1
1992	1
1993	1
1998	1
1999	2
2003	2
2004	3
2005	6
2006	7
2007	17
2008	6
2009	8
2010	13
2011	8
2012	11
2013	4
2014	7
2015	5
2016	7
2017	8
2018	12
2019	8
2020	6
2021	1
2022	3
2023	1
2024	0

1

Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers.

Moton A, Krishna G, Wang Z. Moton A, et al. J Clin Pharm Ther. 2009 Jun;34(3):301-11. doi: 10.1111/j.1365-2710.2009.01055.x. J Clin Pharm Ther. 2009. PMID: 19646076

2

Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

Raad II, Graybill JR, Bustamante AB, Cornely OA, Gaona-Flores V, Afif C, Graham DR, Greenberg RN, Hadley S, Langston A, Negroni R, Perfect JR, Pitisuttithum P, Restrepo A, Schiller G, Pedicone L, Ullmann AJ. Raad II, et al. Clin Infect Dis. 2006 Jun 15;42(12):1726-34. doi: 10.1086/504328. Epub 2006 May 8. Clin Infect Dis. 2006. PMID: 16705579 Clinical Trial.

3

Posaconazole: an extended-spectrum triazole antifungal agent.

Schiller DS, Fung HB. Schiller DS, et al. Clin Ther. 2007 Sep;29(9):1862-86. doi: 10.1016/j.clinthera.2007.09.015. Clin Ther. 2007. PMID: 18035188 Review.

4

Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.

Vaughan D, Speed J, Medve R, Andrews JS. Vaughan D, et al. Clin Ther. 2010 Jan;32(1):146-60. doi: 10.1016/j.clinthera.2010.01.006. Clin Ther. 2010. PMID: 20171420 Clinical Trial.

5

Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects.

Kersemaekers WM, van Iersel T, Nassander U, O'Mara E, Waskin H, Caceres M, van Iersel ML. Kersemaekers WM, et al. Antimicrob Agents Chemother. 2015 Feb;59(2):1246-51. doi: 10.1128/AAC.04223-14. Epub 2014 Dec 15. Antimicrob Agents Chemother. 2015. PMID: 25512407 Free PMC article. Clinical Trial.

6

Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.

Kisicki JC, Fiske K, Lyne A. Kisicki JC, et al. Clin Ther. 2007 Sep;29(9):1967-79. doi: 10.1016/j.clinthera.2007.09.020. Clin Ther. 2007. PMID: 18035196 Clinical Trial.

7

Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans.

Rosenberg G, Angel I, Kozak A. Rosenberg G, et al. Br J Clin Pharmacol. 2005 Jul;60(1):7-16. doi: 10.1111/j.1365-2125.2005.02378.x. Br J Clin Pharmacol. 2005. PMID: 15963088 Free PMC article. Clinical Trial.

8

Evaluation of the pharmacokinetics of posaconazole and rifabutin following co-administration to healthy men.

Krishna G, Parsons A, Kantesaria B, Mant T. Krishna G, et al. Curr Med Res Opin. 2007 Mar;23(3):545-52. doi: 10.1185/030079906X167507. Curr Med Res Opin. 2007. PMID: 17355736 Clinical Trial.

9

Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.

Winston DJ, Bartoni K, Territo MC, Schiller GJ. Winston DJ, et al. Biol Blood Marrow Transplant. 2011 Apr;17(4):507-15. doi: 10.1016/j.bbmt.2010.04.017. Epub 2010 May 9. Biol Blood Marrow Transplant. 2011. PMID: 20460163 Free article. Clinical Trial.

10

Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men.

Krishna G, Sansone-Parsons A, Kantesaria B. Krishna G, et al. Curr Med Res Opin. 2007 Jun;23(6):1415-22. doi: 10.1185/030079907X187937. Epub 2007 May 11. Curr Med Res Opin. 2007. PMID: 17559737 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

135 results

Results by year